BUSINESS● LOWSep 17 · Sep 17, 2026, 12:32 PM
Nuvation Bio rises on FDA label update for Ibtrozi
Seeking Alpha Tech · north america
Nuvation Bio's stock increased following an FDA label update for its drug, Ibtrozi. This indicates a positive development for the pharmaceutical company and its product.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoJohn Lee pledges to showcase Hong Kong’s financial strengths at Apec meetingSouth China Morning PostBUSINESS26m agoSouth Africa: Ramaphosa warns of devastating impact if US trade deal is lostAfricanews [en]